Quality by Design(QbD)
A systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding.
Usage Examples
- QbD principles guided formulation development.
- The design space allowed flexibility in mixing time.
- Control strategy addressed all critical quality attributes.
What is QbD?
Quality by Design (QbD) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.
QbD elements include: Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, design space, control strategy, and lifecycle management. ICH Q8-Q10 guidelines describe QbD principles.
QbD enables regulatory flexibility through design spaces - multidimensional combinations of input variables demonstrated to provide assurance of quality. Working within approved design spaces doesn't require post-approval changes.
Regulatory Context
This term appears most often in cmc & manufacturing workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside ICH Q8, ICH Q9, ICH Q10.
When This Matters
- QbD principles guided formulation development.
- The design space allowed flexibility in mixing time.
- Control strategy addressed all critical quality attributes.
Common Mistakes
- Failing to align CMC change narratives with current CFR/ICH expectations.
- Submitting incomplete control strategy documentation.
- Separating manufacturing and regulatory review cycles too late in execution.
Related Regulations
Frequently Asked Questions
The multidimensional combination and interaction of input variables (e.g., material attributes) and process parameters demonstrated to provide assurance of quality. Working within design space is not considered a change.
QbD is not mandatory but is encouraged. Traditional approaches remain acceptable. QbD provides benefits including better process understanding, reduced manufacturing failures, and regulatory flexibility.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Track ICH quality guidelines automatically and get alerts when changes impact your products
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References

